Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results

par Sormani, M, Molyneux, P, Gasperini, C, Barkhof, F, Yousry, T, Miller, D, Filippi, M
Publié 1999

Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality

par Di Battista, G., Bertolotto, A., Gasperini, C., Ghezzi, A., Maimone, D., Solaro, C.
Publié 2014

Home based management in multiple sclerosis: results of a randomised controlled trial

par Pozzilli, C, Brunetti, M, Amicosante, A, Gasperini, C, Ristori, G, Palmisano, L, Battaglia, M
Publié 2002

Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF: if not multiple sclerosis, what is it?

par Fieschi, C, Gasperini, C, Ristori, G, Bastianello, S, Girmenia, F, Leuzzi, V, Buttinelli, C, Rasura, M
Publié 1995

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.

par Koudriavtseva, T, Thompson, A J, Fiorelli, M, Gasperini, C, Bastianello, S, Bozzao, A, Paolillo, A, Pisani, A, Galgani, S, Pozzilli, C
Publié 1997

Interferon-β-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images

par Gasperini, C., Pozzilli, C., Bastianello, S., Giugni, E., Horsfield, M., Koudriavtseva, T., Galgani, S., Paolillo, A., Haggiag, S., Millefiorini, E., Fieschi, C.
Publié 1999

A controlled study of potential risk factors preceding exacerbation in multiple sclerosis.

par Gasperini, C, Grasso, M G, Fiorelli, M, Millefiorini, E, Morino, S, Anzini, A, Colleluori, A, Salvetti, M, Buttinelli, C, Pozzilli, C
Publié 1995

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

par Pozzilli, C, Bastianello, S, Koudriavtseva, T, Gasperini, C, Bozzao, A, Millefiorini, E, Galgani, S, Buttinelli, C, Perciaccante, G, Piazza, G, Bozzao, L, Fieschi, C
Publié 1996

Interferon β treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology

par Filippi, M, Rovaris, M, Capra, R, Gasperini, C, Prandini, F, Martinelli, V, Horsfield, M, Bastianello, S, Sormani, M, Pozzilli, C, Comi, G
Publié 1999

Tailored Vessel-Catheter Diameter Ratio in a Direct Aspiration First-Pass Technique: Is It a Matter of Caliber?

par Pampana, E., Fabiano, S., De Rubeis, G., Bertaccini, L., Stasolla, A., Vallone, A., Pingi, A., Mangiardi, M., Anticoli, S., Gasperini, C., Cotroneo, E.
Publié dans AJNR Am J Neuroradiol (2021)

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

par Cencioni, M T, Santini, S, Ruocco, G, Borsellino, G, De Bardi, M, Grasso, M G, Ruggieri, S, Gasperini, C, Centonze, D, Barilá, D, Battistini, L, Volpe, E
Publié dans Cell Death Dis (2015)

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients

par Cencioni, M T, Santini, S, Ruocco, G, Borsellino, G, De Bardi, M, Grasso, M G, Ruggieri, S, Gasperini, C, Centonze, D, Barilá, D, Battistini, L, Volpe, E
Publié dans Cell Death Dis (2015)

MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES

par Filippi, M., Rocca, M.A., Ciccarelli, O., De Stefano, N., Evangelou, N., Kappos, L., Rovira, A., Sastre-Garriga, J., Tintorè, M., Frederiksen, J.L., Gasperini, C., Palace, J., Reich, D.S., Banwell, B., Montalban, X., Barkhof, F.
Publié dans Lancet Neurol (2016)

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

par Kearney, H, Rocca, MA, Valsasina, P, Balk, L, Sastre-Garriga, J, Reinhardt, J, Ruggieri, S, Rovira, A, Stippich, C, Kappos, L, Sprenger, T, Tortorella, P, Rovaris, M, Gasperini, C, Montalban, X, Geurts, JJG, Polman, CH, Barkhof, F, Filippi, M, Altmann, DR, Ciccarelli, O, Miller, DH, Chard, DT
Publié 2014

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

par Patti, F, Messina, S, Solaro, C, Amato, M P, Bergamaschi, R, Bonavita, S, Bruno Bossio, R, Brescia Morra, V, Costantino, G F, Cavalla, P, Centonze, D, Comi, G, Cottone, S, Danni, M, Francia, A, Gajofatto, A, Gasperini, C, Ghezzi, A, Iudice, A, Lus, G, Maniscalco, G T, Marrosu, M G, Matta, M, Mirabella, M, Montanari, E, Pozzilli, C, Rovaris, M, Sessa, E, Spitaleri, D, Trojano, M, Valentino, P, Zappia, M
Publié dans J Neurol Neurosurg Psychiatry (2016)